Guardant Health, Inc.

NasdaqGS:GH 주식 보고서

시가총액: US$3.8b

Guardant Health 관리

관리 기준 확인 4/4

Guardant Health CEO는 Helmy Eltoukhy, Jan2013 에 임명되었습니다 의 임기는 11.83 년입니다. 총 연간 보상은 $ 11.59K, 0.01% 로 구성됩니다. 0.01% 급여 및 100% 보너스(회사 주식 및 옵션 포함). 는 $ 81.58M 가치에 해당하는 회사 주식의 2.13% 직접 소유합니다. 81.58M. 경영진과 이사회의 평균 재임 기간은 각각 3.5 년과 3.2 년입니다.

주요 정보

Helmy Eltoukhy

최고 경영자

US$11.6k

총 보상

CEO 급여 비율0.009%
CEO 임기11.8yrs
CEO 소유권2.1%
경영진 평균 재임 기간3.5yrs
이사회 평균 재임 기간3.2yrs

최근 관리 업데이트

Recent updates

Market Participants Recognise Guardant Health, Inc.'s (NASDAQ:GH) Revenues Pushing Shares 36% Higher

Nov 08
Market Participants Recognise Guardant Health, Inc.'s (NASDAQ:GH) Revenues Pushing Shares 36% Higher

An Intrinsic Calculation For Guardant Health, Inc. (NASDAQ:GH) Suggests It's 44% Undervalued

Oct 25
An Intrinsic Calculation For Guardant Health, Inc. (NASDAQ:GH) Suggests It's 44% Undervalued

Is There Now An Opportunity In Guardant Health, Inc. (NASDAQ:GH)?

Sep 24
Is There Now An Opportunity In Guardant Health, Inc. (NASDAQ:GH)?

Guardant Health: Top-Line Growth Undeniable, Compounding Ability Remains Unseen

Aug 21

Guardant Health, Inc.'s (NASDAQ:GH) P/S Is Still On The Mark Following 26% Share Price Bounce

Jul 31
Guardant Health, Inc.'s (NASDAQ:GH) P/S Is Still On The Mark Following 26% Share Price Bounce

Guardant Health, Inc. (NASDAQ:GH) Shares Could Be 49% Below Their Intrinsic Value Estimate

Jul 12
Guardant Health, Inc. (NASDAQ:GH) Shares Could Be 49% Below Their Intrinsic Value Estimate

Guardant: Double-Digit Sales Projections Come At A Cost

Jun 06

Is Now The Time To Look At Buying Guardant Health, Inc. (NASDAQ:GH)?

Jun 04
Is Now The Time To Look At Buying Guardant Health, Inc. (NASDAQ:GH)?

Investors Appear Satisfied With Guardant Health, Inc.'s (NASDAQ:GH) Prospects As Shares Rocket 31%

May 14
Investors Appear Satisfied With Guardant Health, Inc.'s (NASDAQ:GH) Prospects As Shares Rocket 31%

Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

Mar 29
Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

With Guardant Health, Inc. (NASDAQ:GH) It Looks Like You'll Get What You Pay For

Jan 21
With Guardant Health, Inc. (NASDAQ:GH) It Looks Like You'll Get What You Pay For

Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

Nov 20
Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

Is There Now An Opportunity In Guardant Health, Inc. (NASDAQ:GH)?

Sep 26
Is There Now An Opportunity In Guardant Health, Inc. (NASDAQ:GH)?

A Look At The Fair Value Of Guardant Health, Inc. (NASDAQ:GH)

Sep 05
A Look At The Fair Value Of Guardant Health, Inc. (NASDAQ:GH)

Is Guardant Health (NASDAQ:GH) A Risky Investment?

Aug 15
Is Guardant Health (NASDAQ:GH) A Risky Investment?

A Look At The Intrinsic Value Of Guardant Health, Inc. (NASDAQ:GH)

May 28
A Look At The Intrinsic Value Of Guardant Health, Inc. (NASDAQ:GH)

Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

Apr 05
Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

Is Guardant Health (NASDAQ:GH) Using Too Much Debt?

Dec 28
Is Guardant Health (NASDAQ:GH) Using Too Much Debt?

CEO 보상 분석

Helmy Eltoukhy 의 보수는 Guardant Health 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-US$512m

Jun 30 2024n/an/a

-US$491m

Mar 31 2024n/an/a

-US$461m

Dec 31 2023US$12kUS$1

-US$479m

Sep 30 2023n/an/a

-US$432m

Jun 30 2023n/an/a

-US$508m

Mar 31 2023n/an/a

-US$665m

Dec 31 2022US$12kUS$1

-US$655m

Sep 30 2022n/an/a

-US$606m

Jun 30 2022n/an/a

-US$551m

Mar 31 2022n/an/a

-US$419m

Dec 31 2021US$14kUS$1

-US$406m

Sep 30 2021n/an/a

-US$409m

Jun 30 2021n/an/a

-US$379m

Mar 31 2021n/an/a

-US$336m

Dec 31 2020US$114mUS$210k

-US$254m

Sep 30 2020n/an/a

-US$185m

Jun 30 2020n/an/a

-US$120m

Mar 31 2020n/an/a

-US$77m

Dec 31 2019US$915kUS$500k

-US$76m

Sep 30 2019n/an/a

-US$76m

Jun 30 2019n/an/a

-US$87m

Mar 31 2019n/an/a

-US$97m

Dec 31 2018US$818kUS$480k

-US$85m

Sep 30 2018n/an/a

-US$75m

Jun 30 2018n/an/a

-US$84m

Mar 31 2018n/an/a

-US$83m

Dec 31 2017US$4mUS$460k

-US$89m

보상 대 시장: Helmy 의 총 보상 ($USD 11.59K ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 6.60M ).

보상과 수익: Helmy 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Helmy Eltoukhy (45 yo)

11.8yrs

테뉴어

US$11,591

보상

Dr. Helmy Eltoukhy, Ph D., is Partner of Green Sands Equity Incorporated. He is Equity Partner and Advisor of Transform VC.Dr. Eltoukhy has been the Chairman of the Board of Directors of Guardant Health,...

리더십 팀

이름위치테뉴어보상소유권
Helmy Eltoukhy
Co-Founder11.8yrsUS$11.59k2.13%
$ 81.6m
AmirAli Talasaz
Co-CEO & Director3.3yrsUS$26.42k2.2%
$ 84.4m
Michael Bell
Chief Financial Officer3.8yrsUS$4.12m0.019%
$ 746.0k
Darya Chudova
Chief Technology Officerno dataUS$4.76m0.044%
$ 1.7m
Craig Eagle
Chief Medical Officer3.5yrsUS$3.49m0.019%
$ 720.8k
Christopher Freeman
Chief Commercial Officer3.4yrsUS$3.52m0.025%
$ 974.5k
Kumud Kalia
Chief Information Officer4.8yrs데이터 없음0.014%
$ 549.7k
Zarak Khurshid
Vice President of Investor Relationsno data데이터 없음데이터 없음
John Saia
Chief Legal Officer & Corporate Secretary4.5yrsUS$6.02m0.027%
$ 1.0m
Jennifer Higgins
Senior Vice President of Public Affairsno data데이터 없음데이터 없음
Stephen Murphy
Senior Vice President of Marketingless than a year데이터 없음데이터 없음
Terilyn Monroe
Chief People Officerless than a year데이터 없음데이터 없음

3.5yrs

평균 재임 기간

51yo

평균 연령

경험이 풍부한 관리: GH 의 관리팀은 경험 ( 3.5 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Helmy Eltoukhy
Co-Founder11.8yrsUS$11.59k2.13%
$ 81.6m
AmirAli Talasaz
Co-CEO & Director11.8yrsUS$26.42k2.2%
$ 84.4m
Myrtle Potter
Independent Director3.1yrsUS$425.21k0.011%
$ 423.0k
Ian T. Clark
Lead Independent Director7.8yrsUS$470.21k0.0068%
$ 261.4k
Roberto Mignone
Directorless than a year데이터 없음데이터 없음
Steve Krognes
Independent Director2.4yrsUS$425.21k0.0080%
$ 307.0k
Musa Tariq
Independent Director1.7yrsUS$725.30k0.0040%
$ 154.6k
Vijaya Gadde
Independent Director4.4yrsUS$425.21k0.014%
$ 546.6k
Meghan Joyce
Independent Director3.3yrsUS$425.21k0.0062%
$ 236.9k
Manuel Medina
Directorless than a year데이터 없음데이터 없음

3.2yrs

평균 재임 기간

50.5yo

평균 연령

경험이 풍부한 이사회: GH 의 이사회는 경험(평균 재직 기간 3.2 년)으로 간주됩니다.